Eurofins Cerep

Equities

ALECR

FR0013256518

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 10:30:01 2024-04-15 am EDT			5-day change	1st Jan Change
21,800 ^EUR	-0.91%		-.--%	-12.80%

2023	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	CI

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Eurofins Cerep

Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-29	CI
Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI
Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
Global markets live: Daimler, GSK, Mattel	21-04-16
Eurofins Cerep : Launches PCR COVID-19 Self-Test In Germany, Spain	20-12-23	MT
Eurofins-Cerep Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-24	CI
Eurofins Cerep SA acquired KVI-Plusz.	18-07-29	CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, completed the acquisition of a majority stake in Bioaccess S.A.	15-08-03	CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, agreed to acquire majority stake in Bioaccess S.A. for €225 million.	15-06-17	CI
Eurofins-Panlabs, Inc. completed the acquisition of Cerep Inc. from Cerep SA.	13-12-30	CI
Eurofins-Panlabs, Inc. agreed to acquire Cerep Inc. from Cerep SA for $0.27 million.	13-12-12	CI
Eurofins Discovery Services Lux Holding completed the acquisition of 8.48% stake in Cerep SA from Thierry Jean.	13-03-31	CI
Eurofins Scientific SA completed the acquisition of 75.13% stake in Cerep SA for €18.9 million.	13-02-27	CI
Eurofins Scientific SA made an offer to acquire remaining 91.52% stake in Cerep SA for €23.1 million.	12-12-20	CI
Eurofins Discovery Services Lux Holding agreed to acquire 8.48% stake in Cerep SA from Thierry Jean for €2.1 million.	12-12-20	CI

Chart Eurofins Cerep

Duration

Period

More charts

Company Profile

Eurofins Cerep (formerly Eurofins-Cerep) specializes in the pre-clinical research of drugs for the pharmaceutical industry. Exports account for 97.9% of net sales.

Sector

Biotechnology & Medical Research

Calendar

2024-05-22 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EUROFINS CEREP	-12.80%	120M
MODERNA, INC.	+31.37%	50.85B
IQVIA HOLDINGS INC.	+1.21%	42.82B
LONZA GROUP AG	+48.83%	42.03B
CELLTRION, INC.	-4.22%	29.55B
ICON PUBLIC LIMITED COMPANY	+10.98%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-22.30%	19.13B
BIO-TECHNE CORPORATION	+7.59%	13.05B
MEDPACE HOLDINGS, INC.	+26.80%	12.16B
UNITED THERAPEUTICS CORPORATION	+22.92%	12.08B

Other Biotechnology & Medical Research